Research & Trials

Studies we’re building next

These studies are in active protocol development. They are not open yet, and there is nothing to apply to. You can register early interest, and we will reach out the moment a study you might fit opens for screening.

Get notified when these openSee studies recruiting now

What “in development” means

A research study moves through several stages before anyone can take part. These studies are at the earliest one.

Until a study clears ethics review and is registered, key details are not final. Those are who can join, what is involved, timing, and compensation. We do not publish them yet.

  1. Protocol developmentyou are here
  2. IRB review
  3. Registered on ClinicalTrials.gov
  4. Open — recruiting

Not open yet — and not yet an application. Registering interest does not put you in a study and does not decide whether a study is a fit.

The studies

In Development

Young Adult Study — Psilocybin for Treatment-Resistant OCD

A forthcoming study of psilocybin-assisted therapy in a young adult population. What the study asks for, when it opens, and study design details will be posted as the protocol is finalized.

What we can share now

  • Focus: OCD
  • Young adults
  • Psilocybin with non-directive support
  • Yale, in person

Still being decided

  • Exact age range and who can join
  • Study design and dosing
  • Visit schedule
  • Compensation

Learn more

In Development

Group Study — Psilocybin for a Psychiatric Condition (TBD)

A group-format study in development at ENACT, with non-directive support, run in person at Yale. Target condition, what the study asks for, dosing, group structure, timeline and compensation are still being finalised.

What we can share now

  • Group-based model
  • Non-directive support
  • Yale, in person

Still being decided

  • Target condition
  • Who can join
  • Design, dosing and group structure
  • Timeline and compensation

Learn more

Clinicians and referring providers

Caring for a young adult with treatment-resistant OCD, or a patient who might suit a future study? You can register their interest now so they are considered as soon as a relevant study opens.

Studies you can join today

While these are in development, other ENACT studies are actively recruiting.

Questions about these studies? Studies in development, in the FAQ.

Register early interest

Leave your name and we will contact you when a study you choose opens for screening. It does not reserve a place and it does not decide if a study is a fit.

The name we should ask for when a study opens.

One is enough. Email is best for a later notice.

Registering as *

Clinicians can also refer a patient directly.

Notify me about *

You can choose more than one. This is a list, not a queue that decides anything.

This is not an application. You can ask to be removed at any time.

Please share contact details only — do not include health information here. You can ask to be removed at any time.

Not seeing a study for you?

Our studies run in person in New Haven, and each one is looking for something specific. Other universities and hospitals run psychedelic research too.

ClinicalTrials.gov is the U.S. government’s public list of every registered study. You can search it by condition and by where you live.

Search ClinicalTrials.gov (opens in a new tab)

We cannot search it for you, and we cannot refer you to another site.